The global breathable antimicrobial coatings market size was valued at USD 1,286.1 million in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 11.3% from 2023 to 2030. Growing population and high focus towards better healthcare services are expected to fuel the demand over the forecast period. In addition, supportive government regulations and increasing medical device & pharmaceutical manufacturing in developing economies are expected to augment utilization of the product over the forecast period.
Rapid development in antimicrobial technology is expected to play a key role in augmenting market development. Numerous companies namely Microban, Biocote, and Sciessent have been involved in providing effective antimicrobial technologies for numerous industries including medical, food, textiles, and construction.
The University of Dundee has been focused on developing new technologies for medical devices in order to prevent infections and its related diseases. They have developed nanocomposite coatings to reduce bacterial colonization & adhesion, thrombus formation, and prion adhesion.
They have been focusing on developing antimicrobial coatings, especially for implanted medical devices. Similarly, the University of South Australia developed new technology to reduce the risk of infection after biomedical implants such as knee or hip replacement.
The indoor air quality segment accounted for the largest revenue share of 28.5% in 2022 and is expected to grow at the fastest CAGR of 12.6% during the forecast period on account of rising concerns regarding pollution of indoor environment including workplaces
Mold remediation is expected to witness significant growth as the product is highly effective in controlling the moisture content inside the building as well as prevention of molds
North America dominated the global breathable antimicrobial coatings market and accounted for the largest revenue share of 44.0% in 2022 and is expected to grow at the fastest CAGR of 12.3% during the forecast period.
Asia Pacific is expected to witness a CAGR of 11.2% during the forecast period. Rising population coupled with increasing prevalence of hospital-associated infection is expected to fuel growth.
Please note The report will be delivered in 4-8 business days upon order notification.